-
Mashup Score: 17The OncoAlert Newsletter - 8 hour(s) ago
The Latest in Oncology delivered weekly to your inbox, a simple click and you are set to go!
Source: oncoalert.m-pages.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 6CA: A Cancer Journal for Clinicians: Vol 74, No 3 - 15 hour(s) ago
CA: A Cancer Journal for Clinicians is ACS’ flagship clinical oncology journal publishing information about the prevention, early detection, and treatment of cancer.
Categories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 6CA: A Cancer Journal for Clinicians: Vol 74, No 3 - 16 hour(s) ago
CA: A Cancer Journal for Clinicians is ACS’ flagship clinical oncology journal publishing information about the prevention, early detection, and treatment of cancer.
Categories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 2
This overview provides a thorough review of current treatment approaches for first-line management of nononcogenic addicted non–small cell lung cancer. We also address pertinent clinical decision-making queries encountered in everyday practice, such as the optimal treatment strategy for PD-L1–high patients, predictive factors for response to immune checkpoint inhibitors (ICI) both in terms of patient and cancer characteristics, the potential benefits of dual checkpoint blockade, and the unresolved issue of safe discontinuation strategies for long-term responders. Around one in five patients falls into this latter category while the majority develop either primary or acquired resistance to ICI-based first-line therapy, necessitating effective subsequent lines of treatment. Docetaxel, with or without combination of antiangiogenic agents, serves as the backbone of treatment, although evidence in the post-ICI setting is limited. Given that an inflamed tumor microenvironment (TME) is crucia
Source: ascopubs.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 12Home - Precision Oncology - 4 day(s) ago
This EACCME-accredited webinar will cover chronic kidney disease in cardio-renal-metabolic patients and management in primary care.
Categories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 12Home - Precision Oncology - 7 day(s) ago
This EACCME-accredited webinar will cover chronic kidney disease in cardio-renal-metabolic patients and management in primary care.
Categories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 11The GU Cast, Uromigos, OncoAlert Reunion - OncoAlert - 12 day(s) ago
What happens when Five Friends initially brought together by oncology meet up in Lugano for #APCCC24……….Magic…thats what!Join Renu, Declan, Brian, Tom and Gil on this insanely casual and fun conversation on the side
Source: www.buzzsprout.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 8Comparative Evaluation of LLMs in Clinical Oncology - 14 day(s) ago
As artificial intelligence (AI) tools become widely accessible, more patients and medical professionals will turn to them for medical information. Large language models (LLMs), a subset of AI, exce…
Source: ai.nejm.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 2Predicting Ovarian Cancer Relapse With Spatial Tissue Analysis - 15 day(s) ago
Researchers have investigated whether spatial tissue analysis may help predict early posttreatment relapse and illuminate new potential therapies in patients with high-grade serous ovarian carcinoma. …
Source: ascopost.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 15Source: www.youtube.comCategories: General Medicine News, Hem/OncsTweet
A warm welcome to join the @OncoAlert 🚨Newsletter The Latest in Oncology, weekly, simple and delivered straight to your inbox. As always, For Colleagues...By Colleagues!! https://t.co/DjFxZIg4PM